Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Cabozantinib in Advanced SAlivary Gland Cancer Patients, a Phase II Clinical Trial

NCT03729297 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03729297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03729297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Cabozantinib in Advanced SAlivary Gland Cancer Patients, a Phase II Clinical Trial
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
September 5, 2018
Completion date
November 6, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

salivary gland cancer